STERLING SPA

Overview

STERLING SPA is an active pharmaceutical ingredient (API) supplier with 24 active FDA Type II Drug Master Files, covering ABIRATERONE ACETATE; BUDESONIDE; CICLESONIDE; DEFLAZACORT; DESOXYCORTICOSTERONE PIVALATE; DIENOGEST.

API / Drug Master Files

STERLING SPA holds 24 active (24 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NORGESTRELActive2025-02-20
• DIENOGESTActive2022-04-06
• DEFLAZACORTActive2016-03-02
• NOMEGESTROL ACETATE CODE 204622Active2014-03-17
• MOMETASONE FUROATE MONOHYDRATE (D90<10UM)Active2013-03-29
• FULVESTRANTActive2013-01-30
• DESOXYCORTICOSTERONE PIVALATEActive2013-01-07
• ABIRATERONE ACETATEActive2012-11-28
• FLUTICASONE FUROATEActive2011-02-18
• ETONOGESTRELActive2011-02-18
• NOMEGESTROL ACETATEActive2010-06-25
• BUDESONIDEActive2009-03-19
• CICLESONIDEActive2009-02-27
• EXEMESTANEActive2009-01-21
• DROSPIRENONEActive2008-06-27

Showing 15 of 24 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to STERLING SPA in our records. PharmaTek screens the full directory against live FDA enforcement data.